회원로그인

мȸ ǥ ʷ

ǥ : ȣ - 470363   228 
EXTRACARDIAC FONTAN PROCEDURE: EARLY AND INTERMEDIATE RESULTS
Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Sejong Heart Institute
Woong-Han Kim, Joon-Hyuk Kong, Cheong Lim, Soo Cheol Kim, Jae Hyun Kim, Won Min Jo, Hong Ju Seo, Cheul Lee, Yun Hee Chang, Chang Hyun Kang, Song-Wok Whang, Man Jong Baek, Sam Se Oh, Chan Young Na, Young Kwan Park, Chong Whan Kim
Background:. We retrospectively reviewed our experience with 123 patients who underwent the extracardiac conduit Fontan procedures(ECC) between November 1996 and November 2002. Method: There were 53->42 patients(43.1% ->34.1% ) of left (n=22) and right(n=31->20) isomerism. Previous procedures included PAB(n=20), modified BT-shunt(n=29), BCPS(n=92), TCPS(n=11), others(n=6) and none(n=14). Mean intervals between BCPS or TCPS and ECC were 19.1 and 39.9months. Median age, weight at Fontan procedure were 34.5months, 14.0Kg. The means of PVR and PAP were 1.54±0.67 WU and 12.43±3.18mmHg. In 16 patients, atrioventricular valve regurgitation(AVVR) operation was combined. Aortic cross-clamp was avoided in 72 patients. A 14- to 24-mm flexible Gortex tube graft(n=103), Hemashied graft(n=18) or alternatively was used. Fenestration were created in risky Fontan candidates(n=64). The incidence of fenestration has decreased significantly over the course of our experience. Results: Mean follow-up period was 31.7months. There were 3cases(2.4%) of early hospital mortality and no mortality from Jun 2000. There was no significant difference of morbidity and mortality between in AVVR group and in non-AVVR group. New arrhythmia developed in 8cases(6.89%) of 116 preoperative NSR patients during follow-up period: preoperative arrhythmia(n=7), immediate postoperative arrhythmia(n=20), follow-up period arrhythmia(n=14). There were 1 case of Gortex conduit thrombosis due to protein C deficienty and 1 case of Hemashield conduit obstruction by severely thickened endothelial peel. Conclusion: The extracardiac Fontan procedure provides good early and midterm results and low incedence of new developed arrhythmia and conduit complicatioins.


[ư]